Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients
Clinical trial NCT05004675 · COMPLETED
Trial details
- NCT number
- NCT05004675
- Sponsor
- LIB Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-20
- Primary completion
- 2024-05-30
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.